Page 58 - Amgen News Today

Stocks are rising on Wall Street Friday following a government report showing job growth rose modestly in April, a sign that persistently high interest rates may be starting to take a bigger toll on the world's largest economy.

The market ended the week strong as hopes that the Federal Reserve will cut rates are still alive

Apple is rallying on an earnings beat and announcement of a massive buyback; U.S. jobs data are due; Amgen soars after providing an update on a weight loss drug; and Cloudflare plunges on a weak outlook. Here’s what investors need to know today.

NASDAQ does the best today/this week

Amgen (NASDAQ:AMGN) on Thursday said it will stop developing its experimental weight loss pill and instead move forward with its injectable drug and other products in development for obesity. Amgen is among several drugmakers racing to join the ...

Here Comes Obesity Drug Competition: Amgen Shares Soar On "Very Encouraging" Clinical Trial Update Amgen's shares soared in premarket trading in New York…

Wall Street capped a choppy week of trading Friday with the best day for the stock market in over two months, as traders welcomed cooler-than-expected US employment data as...

None Amgen stock soared as much as 16% on Friday after it reported first-quarter earnings. • None The company talked up its experimental GLP-1 weight-loss…

Wall Street rallied on Friday as a softer-than-expected employment report appeared to support the case for Federal Reserve policy easing while also providing evidence of U.S. economic resiliency. ...

News, features, and commentary about cancer-related issues